Skip to main content

Adeno-Associated Virus Vectored Immunoprophylaxis to Prevent HIV: A Phase 1 Randomized Controlled Trial in Healthy Adults

Publication ,  Journal Article
Priddy, FH; Lewis, DJM; Gelderblom, HC; Hassanin, H; Streatfield, C; LaBranche, C; Hare, J; Cox, JH; Dally, L; Bendel, D; Montefiori, D ...
November 8, 2018

Duke Scholars

Publication Date

November 8, 2018
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Priddy, F. H., Lewis, D. J. M., Gelderblom, H. C., Hassanin, H., Streatfield, C., LaBranche, C., … Johnson, P. (2018). Adeno-Associated Virus Vectored Immunoprophylaxis to Prevent HIV: A Phase 1 Randomized Controlled Trial in Healthy Adults.
Priddy, Frances H., David J. M. Lewis, Huub C. Gelderblom, Hana Hassanin, Claire Streatfield, Celia LaBranche, Jonathan Hare, et al. “Adeno-Associated Virus Vectored Immunoprophylaxis to Prevent HIV: A Phase 1 Randomized Controlled Trial in Healthy Adults,” November 8, 2018.
Priddy FH, Lewis DJM, Gelderblom HC, Hassanin H, Streatfield C, LaBranche C, et al. Adeno-Associated Virus Vectored Immunoprophylaxis to Prevent HIV: A Phase 1 Randomized Controlled Trial in Healthy Adults. 2018 Nov 8;
Priddy FH, Lewis DJM, Gelderblom HC, Hassanin H, Streatfield C, LaBranche C, Hare J, Cox JH, Dally L, Bendel D, Montefiori D, Sayeed E, Ackland J, Gilmour J, Schnepp BC, Wright F, Johnson P. Adeno-Associated Virus Vectored Immunoprophylaxis to Prevent HIV: A Phase 1 Randomized Controlled Trial in Healthy Adults. 2018 Nov 8;

Publication Date

November 8, 2018